Late onset oncogenic osteomalacia-associated with neurofibromatosis type II [3]

Clinical Nephrology

Volumn 54, Issue 5, 2000, Pages 429-430

  Haviv, Y S ^a   Silver, J ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCILESS; PHOSPHATE; POTASSIUM DIHYDROGEN PHOSPHATE; SODIUM DIHYDROGEN PHOSPHATE;

ADULT; BONE BIOPSY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; HYPOPHOSPHATEMIA; LETTER; LIMB FRACTURE; NEUROFIBROMATOSIS; ONSET AGE; OSTEOMALACIA; PHOSPHATE METABOLISM; PHOSPHATURIA;

FEMALE; HUMANS; HYPOPHOSPHATEMIA; MIDDLE AGED; NEUROFIBROMATOSIS 2; OSTEOMALACIA;

EID: 0033761571     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Oncogenic osteomalacia induced by schwannoma in a patient with neurofibromatosis
2. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two-hit mechanism of NF2 inactivation
3. Merlin: The neurofibromatosis 2 tumor suppressor
4. Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis
5. Adult hypophosphatemic osteomalacia with Fanconi syndrome presenting in a patient with neuofibromatosis
6. The different forms of neurofibromatosis
7. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules
8. Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis